Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRG-110 Following Intradermal Injection in Healthy Volunteers
Clinical trial NCT03603431 · COMPLETED
Trial details
- NCT number
- NCT03603431
- Sponsor
- miRagen Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-09
- Primary completion
- 2019-03-13
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.